Find information on thousands of medical conditions and prescription drugs.

Microphthalmia

Microphthalmia means small eyes. In mammals the failure of expression of a transcription factor, MITF (microphthalmia-associated transcription factor), in the pigmented retina prevents this structure from fully differentiating. This in turn causes a malformation of the choroid fissure of the eye, resulting in the drainage of vitreous humor fluid. Without this fluid, the eye fails to enlarge, thus the name microphthalmia. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
Mac Ardle disease
Macroglobulinemia
Macular degeneration
Mad cow disease
Maghazaji syndrome
Mal de debarquement
Malaria
Malignant hyperthermia
Mallory-Weiss syndrome
Malouf syndrome
Mannosidosis
Marburg fever
Marfan syndrome
MASA syndrome
Mast cell disease
Mastigophobia
Mastocytosis
Mastoiditis
MAT deficiency
Maturity onset diabetes...
McArdle disease
McCune-Albright syndrome
Measles
Mediterranean fever
Megaloblastic anemia
MELAS
Meleda Disease
Melioidosis
Melkersson-Rosenthal...
Melophobia
Meniere's disease
Meningioma
Meningitis
Mental retardation
Mercury (element)
Mesothelioma
Metabolic acidosis
Metabolic disorder
Metachondromatosis
Methylmalonic acidemia
Microcephaly
Microphobia
Microphthalmia
Microscopic polyangiitis
Microsporidiosis
Microtia, meatal atresia...
Migraine
Miller-Dieker syndrome
Mitochondrial Diseases
Mitochondrial...
Mitral valve prolapse
Mobius syndrome
MODY syndrome
Moebius syndrome
Molluscum contagiosum
MOMO syndrome
Mondini Dysplasia
Mondor's disease
Monoclonal gammopathy of...
Morquio syndrome
Motor neuron disease
Motorphobia
Moyamoya disease
MPO deficiency
MR
Mucopolysaccharidosis
Mucopolysaccharidosis...
Mullerian agenesis
Multiple chemical...
Multiple endocrine...
Multiple hereditary...
Multiple myeloma
Multiple organ failure
Multiple sclerosis
Multiple system atrophy
Mumps
Muscular dystrophy
Myalgic encephalomyelitis
Myasthenia gravis
Mycetoma
Mycophobia
Mycosis fungoides
Myelitis
Myelodysplasia
Myelodysplastic syndromes
Myelofibrosis
Myeloperoxidase deficiency
Myoadenylate deaminase...
Myocarditis
Myoclonus
Myoglobinuria
Myopathy
Myopia
Myositis
Myositis ossificans
Myxedema
Myxozoa
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The gene encoding the microphthalmia-associated transcription factor (Mitf) is a member of the basic helix-loophelix-leucine zipper (bHLH-ZIP) family. Waardenburg syndrome type 2 (WS type 2)in humans is also a type of microphthalmia syndrome. Mutation in MITF gene are thought to be responsible for this syndrome. The human MITF gene is homologous to the mouse MITF gene (aka mouse mi or microphthalmia gene); mouse with mutations in this gene are hypopigmented in their fur. The identification of the genetics of WS type 2 owes a lot to observations of phenotypes of MITF mutant mice.

Read more at Wikipedia.org


[List your site here Free!]


Commentary: clustering of anophthalmia and microphthalmia is not supported by the data - response to 'Geographical variation in anophthalmia and microphthalmia
From British Medical Journal, 10/3/98 by Jack Cuzick

Clustering is a difficult concept to define precisely. It is important to distinguish it from the notion of an individual cluster, corresponding to an excess number of cases in one small area or around a putative point source. A fundamental problem when trying to assess the significance of a specific cluster is that analysis is almost always post-hoc--that is, the cluster is recognised as being unusual by some uncontrolled process, and then a subsequent statistical assessment is made. This is exactly opposite to the situation for which statistical testing was designed--where a hypothesis is first generated and then subsequently tested on new data. As a consequence the vagaries of the spatial and temporal boundaries of the putative cluster make it very difficult to determine the probability of the event being a chance occurrence.

A key aspect of statistical analysis is the concept of replication. If there is a suggestion of clusters at a variety of locations then statistical procedures are more capable of assessing whether this is due to chance. In this sense the analysis of clustering can be viewed as an extension of methods for studying spatial variation to a much smaller scale, where classic mapping procedures no longer are applicable. However, instead of being able to produce a visually appealing map of disease incidence that varies smoothly, here the variability is too localised to allow the averaging necessary to produce such maps, and the more abstract concept of excessive variance must be relied upon.[1]

Many new problems arise in attempting to do this. The most fundamental is how to account for the variation in population density at a very fine scale. Where available a complete population enumeration can be used, but when the scale is very small often it is more accurate to use a sampling scheme for selecting (matched) controls.

A second problem is determining the appropriate metric for establishing closeness. Should it be a fixed distance, as in methods developed by Diggle et al,[2] or should the population density be considered, as in methods developed by Cuzick and Edwards,[3] so that a cluster would encompass a larger area in a low density rural area than in a built up urban area. Other differences relate to whether clusters should be determined by the distance between cases, or the number of cases in predefined geographical areas (eg, wards or postcodes). That distance methods would be more efficient would be suspected, but sometimes this approach is easier to apply to available data, and simulations suggest that the power of these methods are similar.[4]

Clustering methods will always be exploratory, and they leave open the question of what is responsible for the clusters. Their value is to identify clearly when it is worth while to search for causative (infectious or environmental), agents. As more small scale geographical information becomes available for different diseases it is likely that clustering methods will be used more widely. Not only will they help to identify when clustering is present, but as in the present example, they also can rule out localised clustering in favour of a simpler explanation in terms of population density.

[1] Elliott P, Cuzick J, English D, Stern R, eds. Small-area studies: purpose and methods. In: Geographical and enironmental epidemiology : methods for small area studies. Oxford: Oxford University Press; 1992:14-21.

[2] Cuzick J, Edwards R. Spatial clustering for inhomogeneous populations. J Roy Stat Soc B 1990;52:73-104.

[3] Diggle PJ, Chetwynd AG. Second-order analysis of spatial clustering for inhomogeneous populations. Biometrics 1991 ;47:1155-63.

[4] Alexander FE, Boyle P, eds. Methods for investigating localized clustering of disease. Lyons: International Agency for Research on Cancer Scientific Publications, 1996. (No 135.)

Department of Mathematics, Statistics, and Epidemiology, Imperial Cancer Research Fund, PO Box 123, Lincoln's Inn Fields, London WC2A 3PX Jack Cuzick, head

j.cuzick@icrf.icnet.uk

COPYRIGHT 1998 British Medical Association
COPYRIGHT 2000 Gale Group

Return to Microphthalmia
Home Contact Resources Exchange Links ebay